Patents by Inventor Detlef Selent

Detlef Selent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11739106
    Abstract: Bisphosphite ligands based on benzopinacol with an open outer unit, and the use thereof in hydroformylation.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: August 29, 2023
    Assignee: EVONIK OPERATIONS GMBH
    Inventors: Anna Chiara Sale, Robert Franke, Alexander Brächer, Dirk Fridag, Ana Markovic, Peter Kucmierczyk, Johannes Knossalla, Detlef Selent, Armin Börner, Kerstin Romeike
  • Patent number: 11702435
    Abstract: Bisphosphite ligands based on benzopinacol, and the use thereof in hydroformylation.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: July 18, 2023
    Assignee: EVONIK OPERATIONS GMBH
    Inventors: Anna Chiara Sale, Robert Franke, Alexander Brächer, Dirk Fridag, Ana Markovic, Peter Kucmierczyk, Johannes Knossalla, Detlef Selent, Amin Borner, Kerstin Romeike
  • Patent number: 11667657
    Abstract: New diphosphites based on cis-butene-1,4-diol.
    Type: Grant
    Filed: August 16, 2021
    Date of Patent: June 6, 2023
    Assignee: EVONIK OPERATIONS GMBH
    Inventors: Robert Franke, Detlef Selent, Armin Börner, Anna Chiara Sale
  • Publication number: 20220306661
    Abstract: Bisphosphite ligands based on benzopinacol and 1,3-propanediol, and the use thereof in hydroformylation.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 29, 2022
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Anna Chiara SALE, Robert FRANKE, Alexander BRÄCHER, Dirk FRIDAG, Ana MARKOVIC, Peter KUCMIERCZYK, Johannes KNOSSALLA, Detlef SELENT, Armin BÖRNER, Kerstin ROMEIKE
  • Publication number: 20220298183
    Abstract: Bisphosphite ligands based on benzopinacol with an open outer unit, and the use thereof in hydroformylation.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 22, 2022
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Dr. Anna Chiara SALE, Robert FRANKE, Alexander BR.A.CHER, Dirk FRIDAG, Ana MARKOVIC, Peter KUCMIERCZYK, Johannes KNOSSALLA, Detlef SELENT, Armin BORNER, Kerstin ROMEIKE
  • Publication number: 20220298188
    Abstract: Bisphosphite ligands based on benzopinacol, and the use thereof in hydroformylation.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 22, 2022
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Dr. Anna Chiara SALE, Robert FRANKE, Alexander BRACHER, Dirk FRIDAG, Ana MARKOVIC, Peter KUCMIERCZYK, Johannes KNOSSALLA, Detlef SELENT, Amin BORNER, Kerstin ROMEIKE
  • Publication number: 20220298189
    Abstract: Ligands based on phosphonite phosphites, and the use thereof in hydroformylation.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 22, 2022
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Dr. Anna Chiara SALE, Robert FRANKE, Alexander BRACHER, Dirk FRIDAG, Ana MARKOVIC, Peter KUCMIERCZYK, Johannes KNOSSALLA, Detlef SELENT, Armin BORNER, Kerstin ROMEIKE
  • Publication number: 20220056060
    Abstract: New diphosphites based on cis-butene-1,4-diol.
    Type: Application
    Filed: August 16, 2021
    Publication date: February 24, 2022
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Robert Franke, Detlef Selent, Armin Börner, Anna Chiara Sale
  • Publication number: 20220056059
    Abstract: 6,6?-([1,1?-Biphenyl]-2,3?,-diylbis)oxy))didibenzo[d,f][1,3,2]dioxaphosphepines and the use thereof in hydroformylation.
    Type: Application
    Filed: August 16, 2021
    Publication date: February 24, 2022
    Applicant: EVONIK OPERATIONS GMBH
    Inventors: Robert FRANKE, Armin BÖRNER, Svenja Kloss, Detlef Selent
  • Patent number: 10214550
    Abstract: Disclosed herein are compounds of formula (I): wherein: the groups R1, R2, R3, R4, R5, R6, R7, R8, R1?, R2?, R3?, R4?, R5?, R6?, R7?, R8?, R1?, R2?, R3?, R4?, R5?, R6?, R7?, R8? are defined herein; and at least one of the following conditions is satisfied: two radicals from at least one of the four following pairs of radicals are not the same radical: R1? and R8?, R2? and R7?, R3? and R6?, R4? and R5?, and two radicals from at least one of the four following pairs of radicals are not the same radical: R1? and R8?, R2? and R7?, R3? and R6?, R4? and R5?.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: February 26, 2019
    Assignee: Evonik Degussa GmbH
    Inventors: Katrin Marie Dyballa, Robert Franke, Dirk Fridag, Armin Boerner, Detlef Selent
  • Patent number: 10167245
    Abstract: A catalytic method for hydroformylating cyclooctadiene substrate involving forming a reaction mixture that includes the cyclooctadiene and a precursor of or a transitional metal ligand complex where the ligand has structure (1): (1) H2 and CO are fed into the reaction mixture and the mixture is heated to convert the cyclooctadiene into an aldehyde. A preferred ligand is 4-([1,1?:3?,1?-terphenyl]-2?-yloxy)-S-dinaphtho[2,1-d:1?,2?-f][1,3,2]dioxaphosphepine.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: January 1, 2019
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie Dyballa, Robert Franke, Dirk Fridag, Dieter Hess, Detlef Selent, Armin Börner
  • Patent number: 10167244
    Abstract: A catalytic method for hydroformylating a cyclooctadiene substrate involving forming a reaction mixture that includes the cyclooctadiene and a precursor of or a transitional metal ligand complex where the ligand has structure (1): H2 and CO are fed into the reaction mixture and the mixture is heated to convert the cyclooctadiene into an aldehyde. A preferred ligand is 2-(anthracen-9-yloxy)-4,4,5,5-tetramethyl-1,3,2-dioxaphospholane.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: January 1, 2019
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie Dyballa, Robert Franke, Dirk Fridag, Dieter Hess, Detlef Selent, Armin Börner
  • Patent number: 10100071
    Abstract: Novel heterocyclic selenamonophosphites protected on the hydroxyl group, processes for preparation thereof and the use thereof as ligand.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: October 16, 2018
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie Dyballa, Robert Franke, Claudia Weilbeer, Detlef Selent, Armin Börner
  • Publication number: 20180290956
    Abstract: Method for hydroformylating cyclooctadiene using 2-(anthracen-9-yloxy)-4,4,5,5-tetramethyl-1,3,2-dioxaphospholane.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 11, 2018
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie DYBALLA, Robert FRANKE, Dirk FRIDAG, Dieter HESS, Detlef SELENT, Armin BÖRNER
  • Publication number: 20180290958
    Abstract: Method for hydroformylating cyclooctadiene using 4-([1,1?:3?,1?-terphenyl]-2?-yloxy)-S-dinaphtho[2,1-d:1?,2?-f][1,3,2]dioxaphosphepine.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 11, 2018
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie DYBALLA, Robert FRANKE, Dirk FRIDAG, Dieter HESS, Detlef SELENT, Armin BÖRNER
  • Publication number: 20180290957
    Abstract: Process comprising the process steps of: a) initially charging a pentenoic ester, b) adding a ligand of structure 1 or 2: and a compound comprising a metal atom selected from: Rh, Ru, Co, Ir, c) supplying H2 and CO, d) heating the reaction mixture to convert the pentenoic ester to 5-formylpentanoic esters.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 11, 2018
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Stephan BEHRENS, Galina Morales TORRES, Armin BÖRNER, Robert FRANKE, Detlef SELENT
  • Patent number: 10093604
    Abstract: Novel heterocyclic selenabisphosphites, process for preparation thereof and use thereof as ligand unit for preparing ligands for use in complexes.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: October 9, 2018
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie Dyballa, Robert Franke, Claudia Weilbeer, Detlef Selent, Armin Börner
  • Patent number: 10093690
    Abstract: Novel heterocyclic selenaphosphites, process for preparation thereof and use thereof as ligand for employment in complexes.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: October 9, 2018
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie Dyballa, Robert Franke, Claudia Weilbeer, Detlef Selent, Armin Börner
  • Patent number: 9982001
    Abstract: Bisphosphites having an unsymmetric central biaryl unit.
    Type: Grant
    Filed: December 3, 2015
    Date of Patent: May 29, 2018
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Katrin Marie Dyballa, Robert Franke, Dirk Fridag, Armin Börner, Detlef Selent
  • Patent number: 9908910
    Abstract: The invention relates to Rh, Ru, Co and Ir complexes comprising bidentate diphosphoramidites as ligands and to the use thereof as catalysts for the hydroformylation of olefins. The invention also relates to a process for preparing an aldehyde from an olefin using the complexes or ligands mentioned.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: March 6, 2018
    Assignee: Evonik Degussa GmbH
    Inventors: Katrin Marie Dyballa, Robert Franke, Dirk Fridag, Dieter Hess, Frank Geilen, Galina Morales Torres, Detlef Selent, Armin Börner